Celastrol from Celastrus scandens, Anti-inflammatory and antiproliferative agent (ab120655)

Overview

  • Product name

    Celastrol from Celastrus scandens, Anti-inflammatory and antiproliferative agent
  • Description

    Anti-inflammatory and antiproliferative agent
  • Alternative names

    • Tripterine
  • Biological description

    Anti-inflammatory and antiproliferative effects (IC50 = 2.12 µM). Able to modulate multiple cell-signaling pathways (inhibits NF-κB, upregulates cytoplasmic HSP70 and HSP27, suppress VEGF/Akt/mTOR pathways and inhibits TNF-α, proteasome inhibitor).
  • Purity

    > 99%
  • CAS Number

    34157-83-0
  • Chemical structure

    Chemical Structure

Properties

References

This product has been referenced in:

  • Mou H  et al. Celastrol induces apoptosis in non-small-cell lung cancer A549 cells through activation of mitochondria- and Fas/FasL-mediated pathways. Toxicol In Vitro 25:1027-32 (2011). Read more (PubMed: 21466843) »
  • Hansen J  et al. Quantitative proteomics reveals cellular targets of celastrol. PLoS One 6:e26634 (2011). Read more (PubMed: 22046318) »
  • Kannaiyan R  et al. Molecular targets of celastrol derived from Thunder of God Vine: potential role in the treatment of inflammatory disorders and cancer. Cancer Lett 303:9-20 (2011). Read more (PubMed: 21168266) »
  • Allison AC  et al. Celastrol, a potent antioxidant and anti-inflammatory drug, as a possible treatment for Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 25:1341-57 (2001). Read more (PubMed: 11513350) »
  • Bond J  et al. Care of the elderly: nursing homes and continuing care. Part III. Nurs Stand 4:35-7 (0). Read more (PubMed: 2116826) »

Customer reviews and Q&As

There are currently no Customer reviews or Questions for ab120655.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES, NOT FOR USE IN HUMANS"
For licensing inquiries, please contact partnerships@abcam.com

Sign up